nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—EPHX2—hypertension	0.0816	0.217	CbGaD
Sorafenib—RALBP1—hypertension	0.0694	0.185	CbGaD
Sorafenib—FGFR1—hypertension	0.0517	0.138	CbGaD
Sorafenib—FLT1—hypertension	0.0494	0.132	CbGaD
Sorafenib—PDGFRB—hypertension	0.0409	0.109	CbGaD
Sorafenib—HTR2B—hypertension	0.0331	0.0882	CbGaD
Sorafenib—KDR—hypertension	0.031	0.0824	CbGaD
Sorafenib—CYP3A5—hypertension	0.0187	0.0498	CbGaD
Sorafenib—ABCC2—Eprosartan—hypertension	0.00888	0.0264	CbGbCtD
Sorafenib—ABCC2—Reserpine—hypertension	0.006	0.0178	CbGbCtD
Sorafenib—ABCC2—Olmesartan—hypertension	0.006	0.0178	CbGbCtD
Sorafenib—ABCC4—Atorvastatin—hypertension	0.00493	0.0146	CbGbCtD
Sorafenib—UGT1A1—Atorvastatin—hypertension	0.00482	0.0143	CbGbCtD
Sorafenib—ABCC2—Telmisartan—hypertension	0.0048	0.0142	CbGbCtD
Sorafenib—UGT1A1—Losartan—hypertension	0.0044	0.0131	CbGbCtD
Sorafenib—ABCG2—Telmisartan—hypertension	0.00434	0.0129	CbGbCtD
Sorafenib—ABCC2—Spironolactone—hypertension	0.004	0.0119	CbGbCtD
Sorafenib—ABCC4—Verapamil—hypertension	0.00398	0.0118	CbGbCtD
Sorafenib—ABCG2—Prazosin—hypertension	0.00392	0.0116	CbGbCtD
Sorafenib—ABCC2—Nifedipine—hypertension	0.0038	0.0113	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Nisoldipine—hypertension	0.00353	0.0105	CbGbCtD
Sorafenib—CYP3A7—Nisoldipine—hypertension	0.00353	0.0105	CbGbCtD
Sorafenib—CYP2C8—Torasemide—hypertension	0.00349	0.0104	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Diltiazem—hypertension	0.00341	0.0101	CbGbCtD
Sorafenib—CYP3A7—Eplerenone—hypertension	0.00341	0.0101	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Eplerenone—hypertension	0.00341	0.0101	CbGbCtD
Sorafenib—CYP3A7—Diltiazem—hypertension	0.00341	0.0101	CbGbCtD
Sorafenib—CYP2C8—Candesartan—hypertension	0.00324	0.00963	CbGbCtD
Sorafenib—CYP3A5—Reserpine—hypertension	0.003	0.00892	CbGbCtD
Sorafenib—CYP2C9—Eprosartan—hypertension	0.00298	0.00886	CbGbCtD
Sorafenib—ABCC2—Atorvastatin—hypertension	0.00293	0.0087	CbGbCtD
Sorafenib—CYP2C19—Torasemide—hypertension	0.00293	0.00869	CbGbCtD
Sorafenib—ABCC2—Furosemide—hypertension	0.00274	0.00812	CbGbCtD
Sorafenib—CYP3A7—Amlodipine—hypertension	0.00272	0.00809	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Amlodipine—hypertension	0.00272	0.00809	CbGbCtD
Sorafenib—CYP2C19—Metoprolol—hypertension	0.00272	0.00808	CbGbCtD
Sorafenib—CYP2C19—Guanfacine—hypertension	0.00272	0.00808	CbGbCtD
Sorafenib—CYP1A2—Triamterene—hypertension	0.0027	0.00802	CbGbCtD
Sorafenib—CYP1A2—Guanabenz—hypertension	0.0027	0.00802	CbGbCtD
Sorafenib—CYP3A5—Nisoldipine—hypertension	0.00265	0.00786	CbGbCtD
Sorafenib—CYP3A7—Felodipine—hypertension	0.00263	0.0078	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Felodipine—hypertension	0.00263	0.0078	CbGbCtD
Sorafenib—CYP2B6—Amlodipine—hypertension	0.00259	0.0077	CbGbCtD
Sorafenib—ABCB1—Nadolol—hypertension	0.00258	0.00766	CbGbCtD
Sorafenib—CYP3A5—Eplerenone—hypertension	0.00256	0.00759	CbGbCtD
Sorafenib—CYP3A5—Diltiazem—hypertension	0.00256	0.00759	CbGbCtD
Sorafenib—CYP3A7—Nifedipine—hypertension	0.00254	0.00754	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Nifedipine—hypertension	0.00254	0.00754	CbGbCtD
Sorafenib—CYP2C8—Diltiazem—hypertension	0.00246	0.0073	CbGbCtD
Sorafenib—CYP2C9—Torasemide—hypertension	0.00243	0.00722	CbGbCtD
Sorafenib—CYP2D6—Nebivolol—hypertension	0.00243	0.00722	CbGbCtD
Sorafenib—CYP2D6—Labetalol—hypertension	0.00243	0.00722	CbGbCtD
Sorafenib—CYP2B6—Nifedipine—hypertension	0.00242	0.00718	CbGbCtD
Sorafenib—CYP2B6—Nicardipine—hypertension	0.00238	0.00707	CbGbCtD
Sorafenib—ABCC2—Verapamil—hypertension	0.00236	0.00702	CbGbCtD
Sorafenib—ABCB1—Acebutolol—hypertension	0.00236	0.00701	CbGbCtD
Sorafenib—CYP3A7—Propranolol—hypertension	0.0023	0.00683	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Propranolol—hypertension	0.0023	0.00683	CbGbCtD
Sorafenib—CYP2C9—Guanfacine—hypertension	0.00226	0.00671	CbGbCtD
Sorafenib—CYP2C9—Candesartan—hypertension	0.00226	0.00671	CbGbCtD
Sorafenib—CYP1A2—Betaxolol—hypertension	0.00224	0.00664	CbGbCtD
Sorafenib—CYP2D6—Acebutolol—hypertension	0.00222	0.0066	CbGbCtD
Sorafenib—ABCB1—Metoprolol—hypertension	0.00219	0.00652	CbGbCtD
Sorafenib—ABCB1—Candesartan—hypertension	0.00219	0.00652	CbGbCtD
Sorafenib—ABCG2—Verapamil—hypertension	0.00214	0.00635	CbGbCtD
Sorafenib—CYP2C19—Doxazosin—hypertension	0.00213	0.00634	CbGbCtD
Sorafenib—CYP2D6—Pindolol—hypertension	0.00207	0.00614	CbGbCtD
Sorafenib—CYP2D6—Metoprolol—hypertension	0.00207	0.00614	CbGbCtD
Sorafenib—ABCB1—Terazosin—hypertension	0.00206	0.00613	CbGbCtD
Sorafenib—CYP2C19—Diltiazem—hypertension	0.00206	0.00612	CbGbCtD
Sorafenib—CYP3A5—Amlodipine—hypertension	0.00204	0.00607	CbGbCtD
Sorafenib—CYP3A4—Guanethidine—hypertension	0.00204	0.00606	CbGbCtD
Sorafenib—CYP2C8—Irbesartan—hypertension	0.002	0.00595	CbGbCtD
Sorafenib—CYP3A5—Felodipine—hypertension	0.00197	0.00585	CbGbCtD
Sorafenib—CYP1A2—Nisoldipine—hypertension	0.00197	0.00585	CbGbCtD
Sorafenib—CYP2C8—Amlodipine—hypertension	0.00196	0.00583	CbGbCtD
Sorafenib—CYP3A7—Atorvastatin—hypertension	0.00196	0.00581	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Atorvastatin—hypertension	0.00196	0.00581	CbGbCtD
Sorafenib—ABCB1—Reserpine—hypertension	0.00196	0.00581	CbGbCtD
Sorafenib—CYP2C19—Telmisartan—hypertension	0.00194	0.00575	CbGbCtD
Sorafenib—CYP2C8—Spironolactone—hypertension	0.00193	0.00572	CbGbCtD
Sorafenib—CYP3A5—Nifedipine—hypertension	0.00191	0.00566	CbGbCtD
Sorafenib—CYP2C8—Felodipine—hypertension	0.00189	0.00562	CbGbCtD
Sorafenib—CYP3A5—Nicardipine—hypertension	0.00188	0.00557	CbGbCtD
Sorafenib—CYP2B6—Atorvastatin—hypertension	0.00186	0.00553	CbGbCtD
Sorafenib—CYP2D6—Betaxolol—hypertension	0.00184	0.00547	CbGbCtD
Sorafenib—CYP2C8—Nifedipine—hypertension	0.00183	0.00544	CbGbCtD
Sorafenib—CYP2C8—Nicardipine—hypertension	0.0018	0.00535	CbGbCtD
Sorafenib—ABCB1—Perindopril—hypertension	0.00179	0.00531	CbGbCtD
Sorafenib—CYP3A5—Propranolol—hypertension	0.00173	0.00513	CbGbCtD
Sorafenib—ABCB1—Doxazosin—hypertension	0.00172	0.00511	CbGbCtD
Sorafenib—ABCB1—Nisoldipine—hypertension	0.00172	0.00511	CbGbCtD
Sorafenib—CYP2C9—Diltiazem—hypertension	0.00171	0.00509	CbGbCtD
Sorafenib—ABCB1—Diltiazem—hypertension	0.00166	0.00494	CbGbCtD
Sorafenib—CYP3A5—Clonidine—hypertension	0.00165	0.00489	CbGbCtD
Sorafenib—CYP2D6—Doxazosin—hypertension	0.00162	0.00482	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Verapamil—hypertension	0.00158	0.00469	CbGbCtD
Sorafenib—CYP3A7—Verapamil—hypertension	0.00158	0.00469	CbGbCtD
Sorafenib—CYP2C9—Valsartan—hypertension	0.00157	0.00465	CbGbCtD
Sorafenib—CYP2D6—Diltiazem—hypertension	0.00157	0.00465	CbGbCtD
Sorafenib—ABCB1—Telmisartan—hypertension	0.00156	0.00464	CbGbCtD
Sorafenib—CYP2C19—Timolol—hypertension	0.00156	0.00464	CbGbCtD
Sorafenib—CYP1A2—Irbesartan—hypertension	0.00155	0.0046	CbGbCtD
Sorafenib—CYP3A4—Hydralazine—hypertension	0.00155	0.00459	CbGbCtD
Sorafenib—CYP1A2—Amlodipine—hypertension	0.00152	0.00451	CbGbCtD
Sorafenib—CYP2C19—Nicardipine—hypertension	0.00151	0.00449	CbGbCtD
Sorafenib—CYP2B6—Verapamil—hypertension	0.0015	0.00447	CbGbCtD
Sorafenib—ABCB1—Bepridil—hypertension	0.00148	0.0044	CbGbCtD
Sorafenib—ABCB1—Lisinopril—hypertension	0.00148	0.0044	CbGbCtD
Sorafenib—ABCB1—Enalapril—hypertension	0.00148	0.0044	CbGbCtD
Sorafenib—CYP3A5—Atorvastatin—hypertension	0.00147	0.00436	CbGbCtD
Sorafenib—CYP1A2—Nifedipine—hypertension	0.00142	0.00421	CbGbCtD
Sorafenib—ABCB1—Prazosin—hypertension	0.00141	0.0042	CbGbCtD
Sorafenib—CYP2C8—Atorvastatin—hypertension	0.00141	0.00419	CbGbCtD
Sorafenib—CYP2C9—Irbesartan—hypertension	0.0014	0.00415	CbGbCtD
Sorafenib—CYP2D6—Bepridil—hypertension	0.0014	0.00415	CbGbCtD
Sorafenib—CYP1A2—Carvedilol—hypertension	0.0014	0.00414	CbGbCtD
Sorafenib—CYP2C19—Propranolol—hypertension	0.00139	0.00413	CbGbCtD
Sorafenib—CYP2C9—Amlodipine—hypertension	0.00137	0.00407	CbGbCtD
Sorafenib—CYP3A5—Losartan—hypertension	0.00134	0.00399	CbGbCtD
Sorafenib—ABCB1—Amlodipine—hypertension	0.00133	0.00395	CbGbCtD
Sorafenib—CYP2C9—Felodipine—hypertension	0.00132	0.00392	CbGbCtD
Sorafenib—CYP3A4—Guanfacine—hypertension	0.00131	0.0039	CbGbCtD
Sorafenib—ABCB1—Spironolactone—hypertension	0.0013	0.00387	CbGbCtD
Sorafenib—CYP2C8—Losartan—hypertension	0.00129	0.00383	CbGbCtD
Sorafenib—CYP1A2—Propranolol—hypertension	0.00128	0.00381	CbGbCtD
Sorafenib—ABCB1—Felodipine—hypertension	0.00128	0.00381	CbGbCtD
Sorafenib—CYP2C9—Nifedipine—hypertension	0.00128	0.00379	CbGbCtD
Sorafenib—CYP2D6—Irbesartan—hypertension	0.00128	0.00379	CbGbCtD
Sorafenib—ABCB1—Timolol—hypertension	0.00126	0.00374	CbGbCtD
Sorafenib—CYP2C9—Carvedilol—hypertension	0.00126	0.00373	CbGbCtD
Sorafenib—CYP2C9—Nicardipine—hypertension	0.00126	0.00373	CbGbCtD
Sorafenib—CYP2D6—Amlodipine—hypertension	0.00125	0.00372	CbGbCtD
Sorafenib—ABCB1—Nifedipine—hypertension	0.00124	0.00368	CbGbCtD
Sorafenib—CYP1A2—Clonidine—hypertension	0.00123	0.00364	CbGbCtD
Sorafenib—ABCB1—Carvedilol—hypertension	0.00122	0.00362	CbGbCtD
Sorafenib—ABCB1—Nicardipine—hypertension	0.00122	0.00362	CbGbCtD
Sorafenib—CYP2D6—Felodipine—hypertension	0.00121	0.00359	CbGbCtD
Sorafenib—CYP2D6—Timolol—hypertension	0.00119	0.00353	CbGbCtD
Sorafenib—CYP3A5—Verapamil—hypertension	0.00118	0.00352	CbGbCtD
Sorafenib—CYP2C19—Atorvastatin—hypertension	0.00118	0.00352	CbGbCtD
Sorafenib—CYP3A4—Isradipine—hypertension	0.00117	0.00348	CbGbCtD
Sorafenib—CYP2D6—Nifedipine—hypertension	0.00117	0.00347	CbGbCtD
Sorafenib—CYP2D6—Nicardipine—hypertension	0.00115	0.00341	CbGbCtD
Sorafenib—CYP2D6—Carvedilol—hypertension	0.00115	0.00341	CbGbCtD
Sorafenib—CYP2C8—Verapamil—hypertension	0.00114	0.00338	CbGbCtD
Sorafenib—ABCB1—Propranolol—hypertension	0.00112	0.00334	CbGbCtD
Sorafenib—ABCB1—Captopril—hypertension	0.00111	0.00329	CbGbCtD
Sorafenib—CYP2C19—Losartan—hypertension	0.00108	0.00321	CbGbCtD
Sorafenib—ABCB1—Clonidine—hypertension	0.00107	0.00318	CbGbCtD
Sorafenib—CYP2D6—Propranolol—hypertension	0.00106	0.00314	CbGbCtD
Sorafenib—CYP2D6—Captopril—hypertension	0.00105	0.0031	CbGbCtD
Sorafenib—CYP3A4—Nisoldipine—hypertension	0.00103	0.00306	CbGbCtD
Sorafenib—CYP3A4—Indapamide—hypertension	0.00103	0.00306	CbGbCtD
Sorafenib—CYP2D6—Clonidine—hypertension	0.00101	0.003	CbGbCtD
Sorafenib—CYP1A2—Losartan—hypertension	0.000999	0.00297	CbGbCtD
Sorafenib—CYP3A4—Eplerenone—hypertension	0.000996	0.00296	CbGbCtD
Sorafenib—CYP3A4—Diltiazem—hypertension	0.000996	0.00296	CbGbCtD
Sorafenib—CYP2C9—Atorvastatin—hypertension	0.000984	0.00292	CbGbCtD
Sorafenib—Regorafenib—EPHX2—hypertension	0.000969	0.314	CrCbGaD
Sorafenib—CYP2C19—Verapamil—hypertension	0.000955	0.00284	CbGbCtD
Sorafenib—ABCB1—Atorvastatin—hypertension	0.000955	0.00284	CbGbCtD
Sorafenib—CYP2C9—Losartan—hypertension	0.0009	0.00267	CbGbCtD
Sorafenib—CYP2D6—Atorvastatin—hypertension	0.0009	0.00267	CbGbCtD
Sorafenib—CYP3A4—Enalapril—hypertension	0.000888	0.00264	CbGbCtD
Sorafenib—CYP1A2—Verapamil—hypertension	0.000882	0.00262	CbGbCtD
Sorafenib—ABCB1—Losartan—hypertension	0.000874	0.00259	CbGbCtD
Sorafenib—CYP3A4—Irbesartan—hypertension	0.000812	0.00241	CbGbCtD
Sorafenib—CYP3A4—Amlodipine—hypertension	0.000796	0.00237	CbGbCtD
Sorafenib—CYP2C9—Verapamil—hypertension	0.000794	0.00236	CbGbCtD
Sorafenib—ABCB1—Verapamil—hypertension	0.000771	0.00229	CbGbCtD
Sorafenib—CYP3A4—Felodipine—hypertension	0.000768	0.00228	CbGbCtD
Sorafenib—CYP3A4—Nifedipine—hypertension	0.000743	0.00221	CbGbCtD
Sorafenib—CYP3A4—Nicardipine—hypertension	0.000731	0.00217	CbGbCtD
Sorafenib—CYP3A4—Carvedilol—hypertension	0.000731	0.00217	CbGbCtD
Sorafenib—CYP2D6—Verapamil—hypertension	0.000726	0.00216	CbGbCtD
Sorafenib—CYP3A4—Propranolol—hypertension	0.000673	0.002	CbGbCtD
Sorafenib—CYP3A4—Clonidine—hypertension	0.000642	0.00191	CbGbCtD
Sorafenib—Regorafenib—FGFR1—hypertension	0.000614	0.199	CrCbGaD
Sorafenib—Regorafenib—FLT1—hypertension	0.000587	0.19	CrCbGaD
Sorafenib—CYP3A4—Atorvastatin—hypertension	0.000572	0.0017	CbGbCtD
Sorafenib—CYP3A4—Losartan—hypertension	0.000523	0.00155	CbGbCtD
Sorafenib—Regorafenib—PDGFRB—hypertension	0.000485	0.157	CrCbGaD
Sorafenib—CYP3A4—Verapamil—hypertension	0.000462	0.00137	CbGbCtD
Sorafenib—Regorafenib—KDR—hypertension	0.000368	0.119	CrCbGaD
Sorafenib—MKNK1—Pindolol—Nadolol—hypertension	0.000295	0.2	CbGdCrCtD
Sorafenib—MKNK1—Pindolol—Acebutolol—hypertension	0.000259	0.176	CbGdCrCtD
Sorafenib—MKNK1—Pindolol—Metoprolol—hypertension	0.000236	0.16	CbGdCrCtD
Sorafenib—MKNK1—Pindolol—Esmolol—hypertension	0.000223	0.152	CbGdCrCtD
Sorafenib—MKNK1—Pindolol—Betaxolol—hypertension	0.000197	0.134	CbGdCrCtD
Sorafenib—MAP3K7—decidua—hypertension	0.000171	0.00301	CbGeAlD
Sorafenib—MAPK11—central nervous system—hypertension	0.000171	0.00301	CbGeAlD
Sorafenib—MKNK2—heart—hypertension	0.000171	0.003	CbGeAlD
Sorafenib—EPHA6—endocrine gland—hypertension	0.00017	0.003	CbGeAlD
Sorafenib—TIE1—adrenal gland—hypertension	0.00017	0.003	CbGeAlD
Sorafenib—FLT4—cortex of kidney—hypertension	0.00017	0.00298	CbGeAlD
Sorafenib—MKNK2—smooth muscle tissue—hypertension	0.000169	0.00298	CbGeAlD
Sorafenib—RAF1—brainstem—hypertension	0.000168	0.00296	CbGeAlD
Sorafenib—MKNK1—heart—hypertension	0.000168	0.00296	CbGeAlD
Sorafenib—CDK7—central nervous system—hypertension	0.000168	0.00296	CbGeAlD
Sorafenib—FGFR1—cortex of kidney—hypertension	0.000167	0.00294	CbGeAlD
Sorafenib—RET—heart—hypertension	0.000166	0.00293	CbGeAlD
Sorafenib—MKNK2—decidua—hypertension	0.000166	0.00292	CbGeAlD
Sorafenib—AURKC—central nervous system—hypertension	0.000166	0.00292	CbGeAlD
Sorafenib—CYP3A4—urine—hypertension	0.000164	0.00288	CbGeAlD
Sorafenib—MKNK1—decidua—hypertension	0.000164	0.00288	CbGeAlD
Sorafenib—PDGFRB—cardiac ventricle—hypertension	0.000163	0.00287	CbGeAlD
Sorafenib—BRAF—adrenal gland—hypertension	0.000163	0.00287	CbGeAlD
Sorafenib—RALBP1—nephron tubule—hypertension	0.000162	0.00285	CbGeAlD
Sorafenib—RET—decidua—hypertension	0.000162	0.00285	CbGeAlD
Sorafenib—ZAK—endocrine gland—hypertension	0.000161	0.00284	CbGeAlD
Sorafenib—CYP2D6—urine—hypertension	0.000161	0.00284	CbGeAlD
Sorafenib—MKNK2—cardiovascular system—hypertension	0.000161	0.00283	CbGeAlD
Sorafenib—RALBP1—adrenal cortex—hypertension	0.000159	0.0028	CbGeAlD
Sorafenib—FGFR1—cardiac atrium—hypertension	0.000159	0.0028	CbGeAlD
Sorafenib—MKNK1—cardiovascular system—hypertension	0.000159	0.0028	CbGeAlD
Sorafenib—MAP3K7—cortex of kidney—hypertension	0.000158	0.00279	CbGeAlD
Sorafenib—HIPK3—endocrine gland—hypertension	0.000158	0.00278	CbGeAlD
Sorafenib—KIT—myocardium—hypertension	0.000157	0.00277	CbGeAlD
Sorafenib—EPHX2—adrenal gland—hypertension	0.000156	0.00275	CbGeAlD
Sorafenib—FLT3—adrenal gland—hypertension	0.000155	0.00273	CbGeAlD
Sorafenib—RALBP1—heart—hypertension	0.000154	0.00271	CbGeAlD
Sorafenib—FLT1—nephron tubule—hypertension	0.000154	0.00271	CbGeAlD
Sorafenib—RET—kidney—hypertension	0.000154	0.0027	CbGeAlD
Sorafenib—PDGFRB—myocardium—hypertension	0.000154	0.0027	CbGeAlD
Sorafenib—EPHA6—central nervous system—hypertension	0.000153	0.0027	CbGeAlD
Sorafenib—MKNK2—cortex of kidney—hypertension	0.000153	0.0027	CbGeAlD
Sorafenib—RAF1—nephron tubule—hypertension	0.000153	0.00269	CbGeAlD
Sorafenib—RALBP1—smooth muscle tissue—hypertension	0.000153	0.00269	CbGeAlD
Sorafenib—FLT1—adrenal cortex—hypertension	0.000152	0.00267	CbGeAlD
Sorafenib—MKNK1—cortex of kidney—hypertension	0.000152	0.00267	CbGeAlD
Sorafenib—RAF1—adrenal cortex—hypertension	0.000151	0.00265	CbGeAlD
Sorafenib—MAP3K7—cardiac atrium—hypertension	0.000151	0.00265	CbGeAlD
Sorafenib—FGFR1—medulla oblongata—hypertension	0.00015	0.00264	CbGeAlD
Sorafenib—RALBP1—decidua—hypertension	0.00015	0.00264	CbGeAlD
Sorafenib—FLT1—heart—hypertension	0.000147	0.00258	CbGeAlD
Sorafenib—MKNK2—cardiac atrium—hypertension	0.000146	0.00257	CbGeAlD
Sorafenib—RAF1—heart—hypertension	0.000146	0.00256	CbGeAlD
Sorafenib—ZAK—central nervous system—hypertension	0.000145	0.00256	CbGeAlD
Sorafenib—FLT1—smooth muscle tissue—hypertension	0.000145	0.00256	CbGeAlD
Sorafenib—RALBP1—cardiovascular system—hypertension	0.000145	0.00256	CbGeAlD
Sorafenib—EPHB6—heart—hypertension	0.000145	0.00255	CbGeAlD
Sorafenib—RAF1—smooth muscle tissue—hypertension	0.000145	0.00254	CbGeAlD
Sorafenib—MKNK1—cardiac atrium—hypertension	0.000144	0.00254	CbGeAlD
Sorafenib—MAP2K5—brainstem—hypertension	0.000143	0.00252	CbGeAlD
Sorafenib—FLT1—decidua—hypertension	0.000143	0.00251	CbGeAlD
Sorafenib—RALBP1—kidney—hypertension	0.000142	0.0025	CbGeAlD
Sorafenib—CYP3A7-CYP3A51P—nephron tubule—hypertension	0.000142	0.0025	CbGeAlD
Sorafenib—MAP3K7—medulla oblongata—hypertension	0.000142	0.0025	CbGeAlD
Sorafenib—RAF1—decidua—hypertension	0.000142	0.00249	CbGeAlD
Sorafenib—EPHB6—decidua—hypertension	0.000141	0.00248	CbGeAlD
Sorafenib—FLT4—adrenal gland—hypertension	0.000141	0.00248	CbGeAlD
Sorafenib—MAP3K19—central nervous system—hypertension	0.000139	0.00245	CbGeAlD
Sorafenib—FGFR1—adrenal gland—hypertension	0.000139	0.00244	CbGeAlD
Sorafenib—STK10—heart—hypertension	0.000139	0.00244	CbGeAlD
Sorafenib—RALBP1—cortex of kidney—hypertension	0.000139	0.00244	CbGeAlD
Sorafenib—FLT1—cardiovascular system—hypertension	0.000138	0.00243	CbGeAlD
Sorafenib—MKNK2—medulla oblongata—hypertension	0.000138	0.00242	CbGeAlD
Sorafenib—RAF1—cardiovascular system—hypertension	0.000138	0.00242	CbGeAlD
Sorafenib—PDGFRA—heart—hypertension	0.000137	0.00242	CbGeAlD
Sorafenib—PDGFRA—smooth muscle tissue—hypertension	0.000136	0.0024	CbGeAlD
Sorafenib—MKNK1—medulla oblongata—hypertension	0.000136	0.00239	CbGeAlD
Sorafenib—FLT1—kidney—hypertension	0.000135	0.00238	CbGeAlD
Sorafenib—STK10—decidua—hypertension	0.000135	0.00237	CbGeAlD
Sorafenib—RAF1—kidney—hypertension	0.000135	0.00237	CbGeAlD
Sorafenib—FLT3—endocrine gland—hypertension	0.000134	0.00236	CbGeAlD
Sorafenib—RET—medulla oblongata—hypertension	0.000134	0.00236	CbGeAlD
Sorafenib—PDGFRA—decidua—hypertension	0.000134	0.00235	CbGeAlD
Sorafenib—MKNK1—Pindolol—Propranolol—hypertension	0.000133	0.0907	CbGdCrCtD
Sorafenib—TIE1—central nervous system—hypertension	0.000133	0.00234	CbGeAlD
Sorafenib—RALBP1—cardiac atrium—hypertension	0.000132	0.00232	CbGeAlD
Sorafenib—FLT1—cortex of kidney—hypertension	0.000132	0.00232	CbGeAlD
Sorafenib—MAP3K7—adrenal gland—hypertension	0.000131	0.00231	CbGeAlD
Sorafenib—RAF1—cortex of kidney—hypertension	0.000131	0.00231	CbGeAlD
Sorafenib—STK10—cardiovascular system—hypertension	0.000131	0.0023	CbGeAlD
Sorafenib—EPHB6—cortex of kidney—hypertension	0.00013	0.00229	CbGeAlD
Sorafenib—KDR—nephron tubule—hypertension	0.00013	0.00229	CbGeAlD
Sorafenib—PDGFRA—cardiovascular system—hypertension	0.00013	0.00228	CbGeAlD
Sorafenib—KDR—adrenal cortex—hypertension	0.000128	0.00225	CbGeAlD
Sorafenib—MAP2K5—adrenal cortex—hypertension	0.000128	0.00225	CbGeAlD
Sorafenib—STK10—kidney—hypertension	0.000128	0.00225	CbGeAlD
Sorafenib—CDK7—Terbinafine—Propranolol—hypertension	0.000128	0.087	CbGdCrCtD
Sorafenib—MKNK2—adrenal gland—hypertension	0.000127	0.00224	CbGeAlD
Sorafenib—KIT—brainstem—hypertension	0.000127	0.00223	CbGeAlD
Sorafenib—MKNK1—adrenal gland—hypertension	0.000126	0.00221	CbGeAlD
Sorafenib—FLT1—cardiac atrium—hypertension	0.000125	0.00221	CbGeAlD
Sorafenib—CSF1R—adrenal cortex—hypertension	0.000125	0.0022	CbGeAlD
Sorafenib—RAF1—cardiac atrium—hypertension	0.000125	0.00219	CbGeAlD
Sorafenib—RALBP1—medulla oblongata—hypertension	0.000124	0.00219	CbGeAlD
Sorafenib—RET—adrenal gland—hypertension	0.000124	0.00219	CbGeAlD
Sorafenib—EPHB6—cardiac atrium—hypertension	0.000124	0.00218	CbGeAlD
Sorafenib—KDR—heart—hypertension	0.000124	0.00218	CbGeAlD
Sorafenib—MAP2K5—heart—hypertension	0.000124	0.00218	CbGeAlD
Sorafenib—UGT1A9—endocrine gland—hypertension	0.000124	0.00218	CbGeAlD
Sorafenib—KDR—smooth muscle tissue—hypertension	0.000123	0.00216	CbGeAlD
Sorafenib—FLT4—endocrine gland—hypertension	0.000122	0.00215	CbGeAlD
Sorafenib—CYP3A7-CYP3A51P—cortex of kidney—hypertension	0.000122	0.00214	CbGeAlD
Sorafenib—UGT1A1—kidney—hypertension	0.000121	0.00213	CbGeAlD
Sorafenib—CSF1R—heart—hypertension	0.000121	0.00213	CbGeAlD
Sorafenib—MAP2K5—decidua—hypertension	0.000121	0.00212	CbGeAlD
Sorafenib—KDR—decidua—hypertension	0.000121	0.00212	CbGeAlD
Sorafenib—CSF1R—smooth muscle tissue—hypertension	0.00012	0.00211	CbGeAlD
Sorafenib—FLT1—medulla oblongata—hypertension	0.000118	0.00208	CbGeAlD
Sorafenib—CSF1R—decidua—hypertension	0.000118	0.00207	CbGeAlD
Sorafenib—RAF1—medulla oblongata—hypertension	0.000117	0.00207	CbGeAlD
Sorafenib—MAP2K5—cardiovascular system—hypertension	0.000117	0.00206	CbGeAlD
Sorafenib—KDR—cardiovascular system—hypertension	0.000117	0.00206	CbGeAlD
Sorafenib—EPHB6—medulla oblongata—hypertension	0.000117	0.00206	CbGeAlD
Sorafenib—KIT—nephron tubule—hypertension	0.000115	0.00203	CbGeAlD
Sorafenib—RALBP1—adrenal gland—hypertension	0.000115	0.00202	CbGeAlD
Sorafenib—KDR—kidney—hypertension	0.000114	0.00201	CbGeAlD
Sorafenib—CSF1R—cardiovascular system—hypertension	0.000114	0.00201	CbGeAlD
Sorafenib—KDR—cortex of kidney—hypertension	0.000111	0.00196	CbGeAlD
Sorafenib—MAP2K5—cortex of kidney—hypertension	0.000111	0.00196	CbGeAlD
Sorafenib—PDGFRB—adrenal cortex—hypertension	0.000111	0.00195	CbGeAlD
Sorafenib—MKNK2—endocrine gland—hypertension	0.00011	0.00194	CbGeAlD
Sorafenib—KIT—heart—hypertension	0.00011	0.00193	CbGeAlD
Sorafenib—FLT1—adrenal gland—hypertension	0.000109	0.00192	CbGeAlD
Sorafenib—MKNK1—endocrine gland—hypertension	0.000109	0.00192	CbGeAlD
Sorafenib—KIT—smooth muscle tissue—hypertension	0.000109	0.00192	CbGeAlD
Sorafenib—RAF1—adrenal gland—hypertension	0.000109	0.00191	CbGeAlD
Sorafenib—EPHB6—adrenal gland—hypertension	0.000108	0.0019	CbGeAlD
Sorafenib—RET—endocrine gland—hypertension	0.000108	0.0019	CbGeAlD
Sorafenib—PDGFRB—heart—hypertension	0.000107	0.00189	CbGeAlD
Sorafenib—KIT—decidua—hypertension	0.000107	0.00188	CbGeAlD
Sorafenib—PDGFRB—smooth muscle tissue—hypertension	0.000106	0.00187	CbGeAlD
Sorafenib—MAP2K5—cardiac atrium—hypertension	0.000106	0.00186	CbGeAlD
Sorafenib—KDR—cardiac atrium—hypertension	0.000106	0.00186	CbGeAlD
Sorafenib—HTR2C—brainstem—hypertension	0.000105	0.00184	CbGeAlD
Sorafenib—PDGFRB—decidua—hypertension	0.000104	0.00184	CbGeAlD
Sorafenib—KIT—cardiovascular system—hypertension	0.000104	0.00182	CbGeAlD
Sorafenib—STK10—adrenal gland—hypertension	0.000104	0.00182	CbGeAlD
Sorafenib—CSF1R—cardiac atrium—hypertension	0.000103	0.00182	CbGeAlD
Sorafenib—CYP3A7—endocrine gland—hypertension	0.000103	0.00181	CbGeAlD
Sorafenib—PDGFRA—adrenal gland—hypertension	0.000103	0.0018	CbGeAlD
Sorafenib—KIT—kidney—hypertension	0.000101	0.00178	CbGeAlD
Sorafenib—PDGFRB—cardiovascular system—hypertension	0.000101	0.00178	CbGeAlD
Sorafenib—MAP2K5—medulla oblongata—hypertension	9.99e-05	0.00176	CbGeAlD
Sorafenib—KDR—medulla oblongata—hypertension	9.99e-05	0.00176	CbGeAlD
Sorafenib—RALBP1—endocrine gland—hypertension	9.97e-05	0.00175	CbGeAlD
Sorafenib—MKNK2—central nervous system—hypertension	9.95e-05	0.00175	CbGeAlD
Sorafenib—PDGFRB—kidney—hypertension	9.9e-05	0.00174	CbGeAlD
Sorafenib—KIT—cortex of kidney—hypertension	9.87e-05	0.00174	CbGeAlD
Sorafenib—MKNK1—central nervous system—hypertension	9.83e-05	0.00173	CbGeAlD
Sorafenib—CSF1R—medulla oblongata—hypertension	9.75e-05	0.00172	CbGeAlD
Sorafenib—RET—central nervous system—hypertension	9.71e-05	0.00171	CbGeAlD
Sorafenib—PDGFRB—cortex of kidney—hypertension	9.64e-05	0.0017	CbGeAlD
Sorafenib—FLT1—endocrine gland—hypertension	9.49e-05	0.00167	CbGeAlD
Sorafenib—RAF1—endocrine gland—hypertension	9.43e-05	0.00166	CbGeAlD
Sorafenib—MAP2K5—adrenal gland—hypertension	9.25e-05	0.00163	CbGeAlD
Sorafenib—KDR—adrenal gland—hypertension	9.25e-05	0.00163	CbGeAlD
Sorafenib—PDGFRB—cardiac atrium—hypertension	9.17e-05	0.00161	CbGeAlD
Sorafenib—CSF1R—adrenal gland—hypertension	9.03e-05	0.00159	CbGeAlD
Sorafenib—RALBP1—central nervous system—hypertension	8.99e-05	0.00158	CbGeAlD
Sorafenib—STK10—endocrine gland—hypertension	8.98e-05	0.00158	CbGeAlD
Sorafenib—ABCC4—nephron tubule—hypertension	8.97e-05	0.00158	CbGeAlD
Sorafenib—PDGFRA—endocrine gland—hypertension	8.89e-05	0.00156	CbGeAlD
Sorafenib—KIT—medulla oblongata—hypertension	8.85e-05	0.00156	CbGeAlD
Sorafenib—HTR2B—adrenal cortex—hypertension	8.78e-05	0.00155	CbGeAlD
Sorafenib—ABCC2—nephron tubule—hypertension	8.68e-05	0.00153	CbGeAlD
Sorafenib—PDGFRB—medulla oblongata—hypertension	8.65e-05	0.00152	CbGeAlD
Sorafenib—FLT1—central nervous system—hypertension	8.55e-05	0.0015	CbGeAlD
Sorafenib—ABCC4—heart—hypertension	8.54e-05	0.0015	CbGeAlD
Sorafenib—RAF1—central nervous system—hypertension	8.5e-05	0.0015	CbGeAlD
Sorafenib—HTR2B—heart—hypertension	8.49e-05	0.00149	CbGeAlD
Sorafenib—UGT1A1—endocrine gland—hypertension	8.48e-05	0.00149	CbGeAlD
Sorafenib—EPHB6—central nervous system—hypertension	8.45e-05	0.00149	CbGeAlD
Sorafenib—HTR2B—smooth muscle tissue—hypertension	8.43e-05	0.00148	CbGeAlD
Sorafenib—HTR2B—decidua—hypertension	8.26e-05	0.00145	CbGeAlD
Sorafenib—KIT—adrenal gland—hypertension	8.2e-05	0.00144	CbGeAlD
Sorafenib—STK10—central nervous system—hypertension	8.09e-05	0.00142	CbGeAlD
Sorafenib—MAP2K5—endocrine gland—hypertension	8.02e-05	0.00141	CbGeAlD
Sorafenib—KDR—endocrine gland—hypertension	8.02e-05	0.00141	CbGeAlD
Sorafenib—HTR2B—cardiovascular system—hypertension	8.02e-05	0.00141	CbGeAlD
Sorafenib—PDGFRA—central nervous system—hypertension	8.01e-05	0.00141	CbGeAlD
Sorafenib—PDGFRB—adrenal gland—hypertension	8e-05	0.00141	CbGeAlD
Sorafenib—ABCC4—kidney—hypertension	7.88e-05	0.00139	CbGeAlD
Sorafenib—CSF1R—endocrine gland—hypertension	7.83e-05	0.00138	CbGeAlD
Sorafenib—ABCC4—cortex of kidney—hypertension	7.68e-05	0.00135	CbGeAlD
Sorafenib—HTR2B—cortex of kidney—hypertension	7.64e-05	0.00134	CbGeAlD
Sorafenib—ABCC2—kidney—hypertension	7.63e-05	0.00134	CbGeAlD
Sorafenib—ABCC2—cortex of kidney—hypertension	7.43e-05	0.00131	CbGeAlD
Sorafenib—HTR2C—medulla oblongata—hypertension	7.29e-05	0.00128	CbGeAlD
Sorafenib—MAP2K5—central nervous system—hypertension	7.23e-05	0.00127	CbGeAlD
Sorafenib—KDR—central nervous system—hypertension	7.23e-05	0.00127	CbGeAlD
Sorafenib—KIT—endocrine gland—hypertension	7.11e-05	0.00125	CbGeAlD
Sorafenib—CSF1R—central nervous system—hypertension	7.05e-05	0.00124	CbGeAlD
Sorafenib—PDGFRB—endocrine gland—hypertension	6.94e-05	0.00122	CbGeAlD
Sorafenib—Vismodegib—ALB—hypertension	6.65e-05	0.0215	CrCbGaD
Sorafenib—KIT—central nervous system—hypertension	6.4e-05	0.00113	CbGeAlD
Sorafenib—ABCC4—adrenal gland—hypertension	6.37e-05	0.00112	CbGeAlD
Sorafenib—HTR2B—adrenal gland—hypertension	6.34e-05	0.00112	CbGeAlD
Sorafenib—ABCG2—nephron tubule—hypertension	6.33e-05	0.00111	CbGeAlD
Sorafenib—ABCB1—blood vessel—hypertension	6.29e-05	0.00111	CbGeAlD
Sorafenib—PDGFRB—central nervous system—hypertension	6.26e-05	0.0011	CbGeAlD
Sorafenib—ABCG2—adrenal cortex—hypertension	6.23e-05	0.0011	CbGeAlD
Sorafenib—ABCC2—adrenal gland—hypertension	6.17e-05	0.00109	CbGeAlD
Sorafenib—ABCG2—heart—hypertension	6.03e-05	0.00106	CbGeAlD
Sorafenib—CYP3A5—nephron tubule—hypertension	5.88e-05	0.00103	CbGeAlD
Sorafenib—ABCG2—decidua—hypertension	5.86e-05	0.00103	CbGeAlD
Sorafenib—CYP2B6—nephron tubule—hypertension	5.84e-05	0.00103	CbGeAlD
Sorafenib—CYP2B6—adrenal cortex—hypertension	5.75e-05	0.00101	CbGeAlD
Sorafenib—CYP2C8—kidney—hypertension	5.72e-05	0.00101	CbGeAlD
Sorafenib—CYP2B6—heart—hypertension	5.56e-05	0.000978	CbGeAlD
Sorafenib—ABCC4—endocrine gland—hypertension	5.53e-05	0.000972	CbGeAlD
Sorafenib—CYP2C9—heart—hypertension	5.51e-05	0.000969	CbGeAlD
Sorafenib—ABCC2—endocrine gland—hypertension	5.35e-05	0.000941	CbGeAlD
Sorafenib—HTR2C—central nervous system—hypertension	5.27e-05	0.000928	CbGeAlD
Sorafenib—CYP2B6—cardiovascular system—hypertension	5.25e-05	0.000923	CbGeAlD
Sorafenib—CYP2C9—cardiovascular system—hypertension	5.2e-05	0.000914	CbGeAlD
Sorafenib—CYP3A5—kidney—hypertension	5.17e-05	0.000909	CbGeAlD
Sorafenib—CYP2B6—kidney—hypertension	5.13e-05	0.000903	CbGeAlD
Sorafenib—CYP3A5—cortex of kidney—hypertension	5.03e-05	0.000885	CbGeAlD
Sorafenib—ABCC4—central nervous system—hypertension	4.98e-05	0.000876	CbGeAlD
Sorafenib—HTR2B—central nervous system—hypertension	4.95e-05	0.000872	CbGeAlD
Sorafenib—ABCG2—medulla oblongata—hypertension	4.86e-05	0.000855	CbGeAlD
Sorafenib—CYP2D6—brainstem—hypertension	4.78e-05	0.000841	CbGeAlD
Sorafenib—CYP2C19—endocrine gland—hypertension	4.6e-05	0.000809	CbGeAlD
Sorafenib—ABCG2—adrenal gland—hypertension	4.5e-05	0.000792	CbGeAlD
Sorafenib—CYP2B6—adrenal gland—hypertension	4.15e-05	0.00073	CbGeAlD
Sorafenib—CYP2C8—endocrine gland—hypertension	4.01e-05	0.000706	CbGeAlD
Sorafenib—CYP3A4—kidney—hypertension	3.88e-05	0.000682	CbGeAlD
Sorafenib—CYP2D6—kidney—hypertension	3.82e-05	0.000671	CbGeAlD
Sorafenib—CYP1A2—endocrine gland—hypertension	3.75e-05	0.000661	CbGeAlD
Sorafenib—CYP3A5—endocrine gland—hypertension	3.62e-05	0.000637	CbGeAlD
Sorafenib—CYP2B6—endocrine gland—hypertension	3.6e-05	0.000633	CbGeAlD
Sorafenib—CYP2C9—endocrine gland—hypertension	3.56e-05	0.000627	CbGeAlD
Sorafenib—CYP2B6—central nervous system—hypertension	3.24e-05	0.000571	CbGeAlD
Sorafenib—ABCB1—nephron tubule—hypertension	3.12e-05	0.000549	CbGeAlD
Sorafenib—ABCB1—adrenal cortex—hypertension	3.07e-05	0.000541	CbGeAlD
Sorafenib—ABCB1—heart—hypertension	2.97e-05	0.000523	CbGeAlD
Sorafenib—ABCB1—decidua—hypertension	2.89e-05	0.000509	CbGeAlD
Sorafenib—ABCB1—cardiovascular system—hypertension	2.8e-05	0.000494	CbGeAlD
Sorafenib—ABCB1—kidney—hypertension	2.74e-05	0.000483	CbGeAlD
Sorafenib—CYP3A4—endocrine gland—hypertension	2.72e-05	0.000478	CbGeAlD
Sorafenib—CYP2D6—endocrine gland—hypertension	2.67e-05	0.000471	CbGeAlD
Sorafenib—ABCB1—cortex of kidney—hypertension	2.67e-05	0.00047	CbGeAlD
Sorafenib—CYP3A4—central nervous system—hypertension	2.45e-05	0.000431	CbGeAlD
Sorafenib—CYP2D6—central nervous system—hypertension	2.41e-05	0.000424	CbGeAlD
Sorafenib—ABCB1—medulla oblongata—hypertension	2.4e-05	0.000422	CbGeAlD
Sorafenib—ABCB1—adrenal gland—hypertension	2.22e-05	0.00039	CbGeAlD
Sorafenib—ABCB1—endocrine gland—hypertension	1.92e-05	0.000339	CbGeAlD
Sorafenib—ABCB1—central nervous system—hypertension	1.73e-05	0.000305	CbGeAlD
Sorafenib—Leukopenia—Lisinopril—hypertension	1.6e-05	0.000131	CcSEcCtD
Sorafenib—Rash—Fosinopril—hypertension	1.6e-05	0.000131	CcSEcCtD
Sorafenib—Dermatitis—Fosinopril—hypertension	1.6e-05	0.000131	CcSEcCtD
Sorafenib—Vomiting—Nifedipine—hypertension	1.59e-05	0.00013	CcSEcCtD
Sorafenib—Gastrointestinal pain—Furosemide—hypertension	1.59e-05	0.00013	CcSEcCtD
Sorafenib—Rash—Eplerenone—hypertension	1.59e-05	0.00013	CcSEcCtD
Sorafenib—Urticaria—Perindopril—hypertension	1.59e-05	0.00013	CcSEcCtD
Sorafenib—Headache—Fosinopril—hypertension	1.59e-05	0.00013	CcSEcCtD
Sorafenib—Hypersensitivity—Trandolapril—hypertension	1.59e-05	0.00013	CcSEcCtD
Sorafenib—Dermatitis—Eplerenone—hypertension	1.59e-05	0.00013	CcSEcCtD
Sorafenib—Diarrhoea—Valsartan—hypertension	1.59e-05	0.00013	CcSEcCtD
Sorafenib—Asthenia—Clonidine—hypertension	1.59e-05	0.00013	CcSEcCtD
Sorafenib—Vomiting—Verapamil—hypertension	1.58e-05	0.00013	CcSEcCtD
Sorafenib—Urticaria—Irbesartan—hypertension	1.58e-05	0.00013	CcSEcCtD
Sorafenib—Shock—Ramipril—hypertension	1.58e-05	0.00013	CcSEcCtD
Sorafenib—Hypersensitivity—Enalapril—hypertension	1.58e-05	0.00013	CcSEcCtD
Sorafenib—Body temperature increased—Perindopril—hypertension	1.58e-05	0.00013	CcSEcCtD
Sorafenib—Abdominal pain—Perindopril—hypertension	1.58e-05	0.00013	CcSEcCtD
Sorafenib—Diarrhoea—Olmesartan—hypertension	1.58e-05	0.000129	CcSEcCtD
Sorafenib—Headache—Eplerenone—hypertension	1.58e-05	0.000129	CcSEcCtD
Sorafenib—Rash—Nifedipine—hypertension	1.58e-05	0.000129	CcSEcCtD
Sorafenib—Nervous system disorder—Ramipril—hypertension	1.58e-05	0.000129	CcSEcCtD
Sorafenib—Dermatitis—Nifedipine—hypertension	1.58e-05	0.000129	CcSEcCtD
Sorafenib—Body temperature increased—Irbesartan—hypertension	1.58e-05	0.000129	CcSEcCtD
Sorafenib—Abdominal pain—Irbesartan—hypertension	1.58e-05	0.000129	CcSEcCtD
Sorafenib—Thrombocytopenia—Ramipril—hypertension	1.58e-05	0.000129	CcSEcCtD
Sorafenib—Anaphylactic shock—Timolol—hypertension	1.57e-05	0.000129	CcSEcCtD
Sorafenib—Loss of consciousness—Lisinopril—hypertension	1.57e-05	0.000129	CcSEcCtD
Sorafenib—Rash—Verapamil—hypertension	1.57e-05	0.000129	CcSEcCtD
Sorafenib—Urticaria—Hydrochlorothiazide—hypertension	1.57e-05	0.000129	CcSEcCtD
Sorafenib—Dermatitis—Verapamil—hypertension	1.57e-05	0.000129	CcSEcCtD
Sorafenib—Headache—Nifedipine—hypertension	1.57e-05	0.000128	CcSEcCtD
Sorafenib—Pruritus—Clonidine—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Body temperature increased—Hydrochlorothiazide—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Abdominal pain—Hydrochlorothiazide—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Skin disorder—Ramipril—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Infection—Timolol—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Headache—Verapamil—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Hypersensitivity—Telmisartan—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Cough—Lisinopril—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Nausea—Diltiazem—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Nausea—Indapamide—hypertension	1.56e-05	0.000128	CcSEcCtD
Sorafenib—Asthenia—Trandolapril—hypertension	1.55e-05	0.000127	CcSEcCtD
Sorafenib—Shock—Timolol—hypertension	1.55e-05	0.000127	CcSEcCtD
Sorafenib—Urticaria—Furosemide—hypertension	1.55e-05	0.000127	CcSEcCtD
Sorafenib—Nervous system disorder—Timolol—hypertension	1.54e-05	0.000126	CcSEcCtD
Sorafenib—Nausea—Carvedilol—hypertension	1.54e-05	0.000126	CcSEcCtD
Sorafenib—Asthenia—Enalapril—hypertension	1.54e-05	0.000126	CcSEcCtD
Sorafenib—Body temperature increased—Furosemide—hypertension	1.54e-05	0.000126	CcSEcCtD
Sorafenib—Abdominal pain—Furosemide—hypertension	1.54e-05	0.000126	CcSEcCtD
Sorafenib—Gastrointestinal pain—Losartan—hypertension	1.53e-05	0.000126	CcSEcCtD
Sorafenib—Dizziness—Valsartan—hypertension	1.53e-05	0.000126	CcSEcCtD
Sorafenib—Anorexia—Ramipril—hypertension	1.53e-05	0.000126	CcSEcCtD
Sorafenib—Urticaria—Betaxolol—hypertension	1.53e-05	0.000125	CcSEcCtD
Sorafenib—Skin disorder—Timolol—hypertension	1.53e-05	0.000125	CcSEcCtD
Sorafenib—Dizziness—Olmesartan—hypertension	1.53e-05	0.000125	CcSEcCtD
Sorafenib—Pruritus—Trandolapril—hypertension	1.53e-05	0.000125	CcSEcCtD
Sorafenib—Nausea—Doxazosin—hypertension	1.53e-05	0.000125	CcSEcCtD
Sorafenib—Myalgia—Lisinopril—hypertension	1.52e-05	0.000125	CcSEcCtD
Sorafenib—Arthralgia—Lisinopril—hypertension	1.52e-05	0.000125	CcSEcCtD
Sorafenib—Body temperature increased—Betaxolol—hypertension	1.52e-05	0.000125	CcSEcCtD
Sorafenib—Asthenia—Telmisartan—hypertension	1.52e-05	0.000125	CcSEcCtD
Sorafenib—Pruritus—Enalapril—hypertension	1.52e-05	0.000125	CcSEcCtD
Sorafenib—Diarrhoea—Clonidine—hypertension	1.51e-05	0.000124	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.51e-05	0.000124	CcSEcCtD
Sorafenib—Nausea—Fosinopril—hypertension	1.51e-05	0.000123	CcSEcCtD
Sorafenib—Anorexia—Timolol—hypertension	1.5e-05	0.000123	CcSEcCtD
Sorafenib—Pruritus—Telmisartan—hypertension	1.5e-05	0.000123	CcSEcCtD
Sorafenib—Nausea—Eplerenone—hypertension	1.5e-05	0.000123	CcSEcCtD
Sorafenib—Urticaria—Losartan—hypertension	1.49e-05	0.000122	CcSEcCtD
Sorafenib—Dry mouth—Lisinopril—hypertension	1.49e-05	0.000122	CcSEcCtD
Sorafenib—Nausea—Nifedipine—hypertension	1.49e-05	0.000122	CcSEcCtD
Sorafenib—Body temperature increased—Losartan—hypertension	1.48e-05	0.000122	CcSEcCtD
Sorafenib—Abdominal pain—Losartan—hypertension	1.48e-05	0.000122	CcSEcCtD
Sorafenib—Nausea—Verapamil—hypertension	1.48e-05	0.000121	CcSEcCtD
Sorafenib—Asthenia—Captopril—hypertension	1.48e-05	0.000121	CcSEcCtD
Sorafenib—Diarrhoea—Trandolapril—hypertension	1.48e-05	0.000121	CcSEcCtD
Sorafenib—Vomiting—Valsartan—hypertension	1.48e-05	0.000121	CcSEcCtD
Sorafenib—Diarrhoea—Enalapril—hypertension	1.47e-05	0.00012	CcSEcCtD
Sorafenib—Hypersensitivity—Irbesartan—hypertension	1.47e-05	0.00012	CcSEcCtD
Sorafenib—Vomiting—Olmesartan—hypertension	1.47e-05	0.00012	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Ramipril—hypertension	1.47e-05	0.00012	CcSEcCtD
Sorafenib—Rash—Valsartan—hypertension	1.46e-05	0.00012	CcSEcCtD
Sorafenib—Dizziness—Clonidine—hypertension	1.46e-05	0.00012	CcSEcCtD
Sorafenib—Dermatitis—Valsartan—hypertension	1.46e-05	0.00012	CcSEcCtD
Sorafenib—Anaphylactic shock—Lisinopril—hypertension	1.46e-05	0.00012	CcSEcCtD
Sorafenib—Pruritus—Captopril—hypertension	1.46e-05	0.000119	CcSEcCtD
Sorafenib—Hypersensitivity—Hydrochlorothiazide—hypertension	1.46e-05	0.000119	CcSEcCtD
Sorafenib—Rash—Olmesartan—hypertension	1.46e-05	0.000119	CcSEcCtD
Sorafenib—Dermatitis—Olmesartan—hypertension	1.45e-05	0.000119	CcSEcCtD
Sorafenib—Headache—Valsartan—hypertension	1.45e-05	0.000119	CcSEcCtD
Sorafenib—Diarrhoea—Telmisartan—hypertension	1.45e-05	0.000119	CcSEcCtD
Sorafenib—Infection—Lisinopril—hypertension	1.45e-05	0.000119	CcSEcCtD
Sorafenib—Headache—Olmesartan—hypertension	1.45e-05	0.000119	CcSEcCtD
Sorafenib—Shock—Lisinopril—hypertension	1.44e-05	0.000118	CcSEcCtD
Sorafenib—Asthenia—Perindopril—hypertension	1.44e-05	0.000118	CcSEcCtD
Sorafenib—Dyspnoea—Ramipril—hypertension	1.43e-05	0.000118	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Timolol—hypertension	1.43e-05	0.000117	CcSEcCtD
Sorafenib—Hypersensitivity—Furosemide—hypertension	1.43e-05	0.000117	CcSEcCtD
Sorafenib—Asthenia—Irbesartan—hypertension	1.43e-05	0.000117	CcSEcCtD
Sorafenib—Thrombocytopenia—Lisinopril—hypertension	1.43e-05	0.000117	CcSEcCtD
Sorafenib—Dizziness—Trandolapril—hypertension	1.43e-05	0.000117	CcSEcCtD
Sorafenib—Dizziness—Enalapril—hypertension	1.42e-05	0.000116	CcSEcCtD
Sorafenib—Asthenia—Hydrochlorothiazide—hypertension	1.42e-05	0.000116	CcSEcCtD
Sorafenib—Hypersensitivity—Betaxolol—hypertension	1.42e-05	0.000116	CcSEcCtD
Sorafenib—Skin disorder—Lisinopril—hypertension	1.42e-05	0.000116	CcSEcCtD
Sorafenib—Dyspepsia—Ramipril—hypertension	1.42e-05	0.000116	CcSEcCtD
Sorafenib—Pruritus—Perindopril—hypertension	1.42e-05	0.000116	CcSEcCtD
Sorafenib—Pruritus—Irbesartan—hypertension	1.41e-05	0.000116	CcSEcCtD
Sorafenib—Diarrhoea—Captopril—hypertension	1.41e-05	0.000116	CcSEcCtD
Sorafenib—Vomiting—Clonidine—hypertension	1.41e-05	0.000115	CcSEcCtD
Sorafenib—Dyspnoea—Timolol—hypertension	1.4e-05	0.000115	CcSEcCtD
Sorafenib—Dizziness—Telmisartan—hypertension	1.4e-05	0.000115	CcSEcCtD
Sorafenib—Pruritus—Hydrochlorothiazide—hypertension	1.4e-05	0.000115	CcSEcCtD
Sorafenib—Decreased appetite—Ramipril—hypertension	1.4e-05	0.000115	CcSEcCtD
Sorafenib—Asthenia—Furosemide—hypertension	1.4e-05	0.000114	CcSEcCtD
Sorafenib—Rash—Clonidine—hypertension	1.39e-05	0.000114	CcSEcCtD
Sorafenib—Dermatitis—Clonidine—hypertension	1.39e-05	0.000114	CcSEcCtD
Sorafenib—Anorexia—Lisinopril—hypertension	1.39e-05	0.000114	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Ramipril—hypertension	1.39e-05	0.000114	CcSEcCtD
Sorafenib—Fatigue—Ramipril—hypertension	1.39e-05	0.000114	CcSEcCtD
Sorafenib—Headache—Clonidine—hypertension	1.39e-05	0.000114	CcSEcCtD
Sorafenib—Dyspepsia—Timolol—hypertension	1.38e-05	0.000113	CcSEcCtD
Sorafenib—Hypersensitivity—Losartan—hypertension	1.38e-05	0.000113	CcSEcCtD
Sorafenib—Asthenia—Betaxolol—hypertension	1.38e-05	0.000113	CcSEcCtD
Sorafenib—Nausea—Valsartan—hypertension	1.38e-05	0.000113	CcSEcCtD
Sorafenib—Pruritus—Furosemide—hypertension	1.38e-05	0.000113	CcSEcCtD
Sorafenib—Constipation—Ramipril—hypertension	1.38e-05	0.000113	CcSEcCtD
Sorafenib—Nausea—Olmesartan—hypertension	1.37e-05	0.000112	CcSEcCtD
Sorafenib—Vomiting—Trandolapril—hypertension	1.37e-05	0.000112	CcSEcCtD
Sorafenib—Diarrhoea—Perindopril—hypertension	1.37e-05	0.000112	CcSEcCtD
Sorafenib—Decreased appetite—Timolol—hypertension	1.37e-05	0.000112	CcSEcCtD
Sorafenib—Vomiting—Enalapril—hypertension	1.37e-05	0.000112	CcSEcCtD
Sorafenib—Diarrhoea—Irbesartan—hypertension	1.36e-05	0.000112	CcSEcCtD
Sorafenib—Dizziness—Captopril—hypertension	1.36e-05	0.000112	CcSEcCtD
Sorafenib—Pruritus—Betaxolol—hypertension	1.36e-05	0.000112	CcSEcCtD
Sorafenib—Rash—Trandolapril—hypertension	1.36e-05	0.000111	CcSEcCtD
Sorafenib—Dermatitis—Trandolapril—hypertension	1.36e-05	0.000111	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Timolol—hypertension	1.36e-05	0.000111	CcSEcCtD
Sorafenib—Fatigue—Timolol—hypertension	1.36e-05	0.000111	CcSEcCtD
Sorafenib—Rash—Enalapril—hypertension	1.35e-05	0.000111	CcSEcCtD
Sorafenib—Dermatitis—Enalapril—hypertension	1.35e-05	0.000111	CcSEcCtD
Sorafenib—Diarrhoea—Hydrochlorothiazide—hypertension	1.35e-05	0.000111	CcSEcCtD
Sorafenib—Headache—Trandolapril—hypertension	1.35e-05	0.000111	CcSEcCtD
Sorafenib—Vomiting—Telmisartan—hypertension	1.35e-05	0.00011	CcSEcCtD
Sorafenib—Asthenia—Losartan—hypertension	1.35e-05	0.00011	CcSEcCtD
Sorafenib—Headache—Enalapril—hypertension	1.35e-05	0.00011	CcSEcCtD
Sorafenib—Pain—Timolol—hypertension	1.35e-05	0.00011	CcSEcCtD
Sorafenib—Rash—Telmisartan—hypertension	1.34e-05	0.000109	CcSEcCtD
Sorafenib—Dermatitis—Telmisartan—hypertension	1.34e-05	0.000109	CcSEcCtD
Sorafenib—Diarrhoea—Furosemide—hypertension	1.33e-05	0.000109	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Lisinopril—hypertension	1.33e-05	0.000109	CcSEcCtD
Sorafenib—Pruritus—Losartan—hypertension	1.33e-05	0.000109	CcSEcCtD
Sorafenib—Headache—Telmisartan—hypertension	1.33e-05	0.000109	CcSEcCtD
Sorafenib—Dizziness—Perindopril—hypertension	1.32e-05	0.000108	CcSEcCtD
Sorafenib—Dizziness—Irbesartan—hypertension	1.32e-05	0.000108	CcSEcCtD
Sorafenib—Diarrhoea—Betaxolol—hypertension	1.32e-05	0.000108	CcSEcCtD
Sorafenib—Gastrointestinal pain—Ramipril—hypertension	1.32e-05	0.000108	CcSEcCtD
Sorafenib—Nausea—Clonidine—hypertension	1.31e-05	0.000108	CcSEcCtD
Sorafenib—Vomiting—Captopril—hypertension	1.31e-05	0.000107	CcSEcCtD
Sorafenib—Dizziness—Hydrochlorothiazide—hypertension	1.31e-05	0.000107	CcSEcCtD
Sorafenib—Dyspnoea—Lisinopril—hypertension	1.3e-05	0.000107	CcSEcCtD
Sorafenib—Rash—Captopril—hypertension	1.3e-05	0.000106	CcSEcCtD
Sorafenib—Dermatitis—Captopril—hypertension	1.3e-05	0.000106	CcSEcCtD
Sorafenib—Headache—Captopril—hypertension	1.29e-05	0.000106	CcSEcCtD
Sorafenib—Gastrointestinal pain—Timolol—hypertension	1.29e-05	0.000105	CcSEcCtD
Sorafenib—Dizziness—Furosemide—hypertension	1.29e-05	0.000105	CcSEcCtD
Sorafenib—Dyspepsia—Lisinopril—hypertension	1.28e-05	0.000105	CcSEcCtD
Sorafenib—Diarrhoea—Losartan—hypertension	1.28e-05	0.000105	CcSEcCtD
Sorafenib—Nausea—Trandolapril—hypertension	1.28e-05	0.000105	CcSEcCtD
Sorafenib—Urticaria—Ramipril—hypertension	1.28e-05	0.000105	CcSEcCtD
Sorafenib—Nausea—Enalapril—hypertension	1.28e-05	0.000105	CcSEcCtD
Sorafenib—Dizziness—Betaxolol—hypertension	1.27e-05	0.000104	CcSEcCtD
Sorafenib—Vomiting—Perindopril—hypertension	1.27e-05	0.000104	CcSEcCtD
Sorafenib—Abdominal pain—Ramipril—hypertension	1.27e-05	0.000104	CcSEcCtD
Sorafenib—Body temperature increased—Ramipril—hypertension	1.27e-05	0.000104	CcSEcCtD
Sorafenib—Decreased appetite—Lisinopril—hypertension	1.27e-05	0.000104	CcSEcCtD
Sorafenib—Vomiting—Irbesartan—hypertension	1.27e-05	0.000104	CcSEcCtD
Sorafenib—Rash—Perindopril—hypertension	1.26e-05	0.000103	CcSEcCtD
Sorafenib—Dermatitis—Perindopril—hypertension	1.26e-05	0.000103	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Lisinopril—hypertension	1.26e-05	0.000103	CcSEcCtD
Sorafenib—Nausea—Telmisartan—hypertension	1.26e-05	0.000103	CcSEcCtD
Sorafenib—Fatigue—Lisinopril—hypertension	1.26e-05	0.000103	CcSEcCtD
Sorafenib—Vomiting—Hydrochlorothiazide—hypertension	1.26e-05	0.000103	CcSEcCtD
Sorafenib—Rash—Irbesartan—hypertension	1.26e-05	0.000103	CcSEcCtD
Sorafenib—Dermatitis—Irbesartan—hypertension	1.26e-05	0.000103	CcSEcCtD
Sorafenib—Headache—Perindopril—hypertension	1.25e-05	0.000103	CcSEcCtD
Sorafenib—Urticaria—Timolol—hypertension	1.25e-05	0.000102	CcSEcCtD
Sorafenib—Headache—Irbesartan—hypertension	1.25e-05	0.000102	CcSEcCtD
Sorafenib—Pain—Lisinopril—hypertension	1.25e-05	0.000102	CcSEcCtD
Sorafenib—Constipation—Lisinopril—hypertension	1.25e-05	0.000102	CcSEcCtD
Sorafenib—Rash—Hydrochlorothiazide—hypertension	1.25e-05	0.000102	CcSEcCtD
Sorafenib—Dermatitis—Hydrochlorothiazide—hypertension	1.25e-05	0.000102	CcSEcCtD
Sorafenib—Abdominal pain—Timolol—hypertension	1.24e-05	0.000102	CcSEcCtD
Sorafenib—Body temperature increased—Timolol—hypertension	1.24e-05	0.000102	CcSEcCtD
Sorafenib—Dizziness—Losartan—hypertension	1.24e-05	0.000102	CcSEcCtD
Sorafenib—Headache—Hydrochlorothiazide—hypertension	1.24e-05	0.000102	CcSEcCtD
Sorafenib—Vomiting—Furosemide—hypertension	1.24e-05	0.000101	CcSEcCtD
Sorafenib—Rash—Furosemide—hypertension	1.23e-05	0.0001	CcSEcCtD
Sorafenib—Dermatitis—Furosemide—hypertension	1.23e-05	0.0001	CcSEcCtD
Sorafenib—Vomiting—Betaxolol—hypertension	1.22e-05	0.0001	CcSEcCtD
Sorafenib—Nausea—Captopril—hypertension	1.22e-05	0.0001	CcSEcCtD
Sorafenib—Headache—Furosemide—hypertension	1.22e-05	9.98e-05	CcSEcCtD
Sorafenib—Rash—Betaxolol—hypertension	1.21e-05	9.95e-05	CcSEcCtD
Sorafenib—Dermatitis—Betaxolol—hypertension	1.21e-05	9.94e-05	CcSEcCtD
Sorafenib—Headache—Betaxolol—hypertension	1.21e-05	9.88e-05	CcSEcCtD
Sorafenib—Gastrointestinal pain—Lisinopril—hypertension	1.19e-05	9.78e-05	CcSEcCtD
Sorafenib—Vomiting—Losartan—hypertension	1.19e-05	9.78e-05	CcSEcCtD
Sorafenib—Nausea—Perindopril—hypertension	1.19e-05	9.74e-05	CcSEcCtD
Sorafenib—Hypersensitivity—Ramipril—hypertension	1.19e-05	9.71e-05	CcSEcCtD
Sorafenib—Nausea—Irbesartan—hypertension	1.18e-05	9.7e-05	CcSEcCtD
Sorafenib—Rash—Losartan—hypertension	1.18e-05	9.69e-05	CcSEcCtD
Sorafenib—Dermatitis—Losartan—hypertension	1.18e-05	9.68e-05	CcSEcCtD
Sorafenib—Headache—Losartan—hypertension	1.18e-05	9.63e-05	CcSEcCtD
Sorafenib—Nausea—Hydrochlorothiazide—hypertension	1.17e-05	9.62e-05	CcSEcCtD
Sorafenib—Urticaria—Lisinopril—hypertension	1.16e-05	9.5e-05	CcSEcCtD
Sorafenib—Hypersensitivity—Timolol—hypertension	1.16e-05	9.49e-05	CcSEcCtD
Sorafenib—Nausea—Furosemide—hypertension	1.16e-05	9.46e-05	CcSEcCtD
Sorafenib—Asthenia—Ramipril—hypertension	1.15e-05	9.46e-05	CcSEcCtD
Sorafenib—Abdominal pain—Lisinopril—hypertension	1.15e-05	9.45e-05	CcSEcCtD
Sorafenib—Body temperature increased—Lisinopril—hypertension	1.15e-05	9.45e-05	CcSEcCtD
Sorafenib—Nausea—Betaxolol—hypertension	1.14e-05	9.37e-05	CcSEcCtD
Sorafenib—Pruritus—Ramipril—hypertension	1.14e-05	9.33e-05	CcSEcCtD
Sorafenib—Asthenia—Timolol—hypertension	1.13e-05	9.25e-05	CcSEcCtD
Sorafenib—Nausea—Losartan—hypertension	1.11e-05	9.13e-05	CcSEcCtD
Sorafenib—Pruritus—Timolol—hypertension	1.11e-05	9.12e-05	CcSEcCtD
Sorafenib—Diarrhoea—Ramipril—hypertension	1.1e-05	9.02e-05	CcSEcCtD
Sorafenib—Diarrhoea—Timolol—hypertension	1.08e-05	8.82e-05	CcSEcCtD
Sorafenib—Hypersensitivity—Lisinopril—hypertension	1.08e-05	8.81e-05	CcSEcCtD
Sorafenib—Dizziness—Ramipril—hypertension	1.06e-05	8.72e-05	CcSEcCtD
Sorafenib—Asthenia—Lisinopril—hypertension	1.05e-05	8.58e-05	CcSEcCtD
Sorafenib—Dizziness—Timolol—hypertension	1.04e-05	8.52e-05	CcSEcCtD
Sorafenib—Pruritus—Lisinopril—hypertension	1.03e-05	8.46e-05	CcSEcCtD
Sorafenib—Vomiting—Ramipril—hypertension	1.02e-05	8.38e-05	CcSEcCtD
Sorafenib—Rash—Ramipril—hypertension	1.01e-05	8.31e-05	CcSEcCtD
Sorafenib—Dermatitis—Ramipril—hypertension	1.01e-05	8.3e-05	CcSEcCtD
Sorafenib—Headache—Ramipril—hypertension	1.01e-05	8.26e-05	CcSEcCtD
Sorafenib—Vomiting—Timolol—hypertension	1e-05	8.19e-05	CcSEcCtD
Sorafenib—Diarrhoea—Lisinopril—hypertension	9.99e-06	8.18e-05	CcSEcCtD
Sorafenib—Rash—Timolol—hypertension	9.92e-06	8.13e-05	CcSEcCtD
Sorafenib—Dermatitis—Timolol—hypertension	9.91e-06	8.12e-05	CcSEcCtD
Sorafenib—Headache—Timolol—hypertension	9.86e-06	8.07e-05	CcSEcCtD
Sorafenib—Dizziness—Lisinopril—hypertension	9.65e-06	7.91e-05	CcSEcCtD
Sorafenib—Nausea—Ramipril—hypertension	9.56e-06	7.83e-05	CcSEcCtD
Sorafenib—Nausea—Timolol—hypertension	9.34e-06	7.65e-05	CcSEcCtD
Sorafenib—Vomiting—Lisinopril—hypertension	9.28e-06	7.6e-05	CcSEcCtD
Sorafenib—Rash—Lisinopril—hypertension	9.2e-06	7.54e-05	CcSEcCtD
Sorafenib—Dermatitis—Lisinopril—hypertension	9.19e-06	7.53e-05	CcSEcCtD
Sorafenib—Headache—Lisinopril—hypertension	9.14e-06	7.49e-05	CcSEcCtD
Sorafenib—Nausea—Lisinopril—hypertension	8.67e-06	7.1e-05	CcSEcCtD
Sorafenib—CYP2C9—Metabolism—CYP1A1—hypertension	2.93e-07	2.82e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—EGFR—hypertension	2.93e-07	2.82e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—MTHFR—hypertension	2.92e-07	2.81e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—VEGFA—hypertension	2.92e-07	2.81e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—EGFR—hypertension	2.92e-07	2.81e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	2.92e-07	2.8e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CD36—hypertension	2.91e-07	2.8e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MMP9—hypertension	2.9e-07	2.79e-06	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—AKT1—hypertension	2.89e-07	2.78e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CDKN1A—hypertension	2.89e-07	2.78e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ALB—hypertension	2.89e-07	2.78e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—COMT—hypertension	2.89e-07	2.78e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—IL6—hypertension	2.89e-07	2.78e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CTGF—hypertension	2.89e-07	2.78e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—AKT1—hypertension	2.88e-07	2.77e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PTEN—hypertension	2.88e-07	2.77e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CD36—hypertension	2.88e-07	2.77e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MTOR—hypertension	2.88e-07	2.77e-06	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TP53—hypertension	2.87e-07	2.76e-06	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—EP300—hypertension	2.87e-07	2.76e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PPARA—hypertension	2.87e-07	2.76e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—SRC—hypertension	2.86e-07	2.75e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—HMGCR—hypertension	2.86e-07	2.75e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GOT2—hypertension	2.86e-07	2.75e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GNB3—hypertension	2.85e-07	2.74e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PPARGC1A—hypertension	2.85e-07	2.74e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—AGT—hypertension	2.85e-07	2.74e-06	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TP53—hypertension	2.85e-07	2.74e-06	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—EP300—hypertension	2.84e-07	2.74e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—HMOX1—hypertension	2.83e-07	2.73e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ALB—hypertension	2.83e-07	2.72e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MAPK8—hypertension	2.82e-07	2.71e-06	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—AKT1—hypertension	2.82e-07	2.71e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—AKT1—hypertension	2.81e-07	2.71e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ADRA2A—hypertension	2.8e-07	2.69e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CALM1—hypertension	2.8e-07	2.69e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CAT—hypertension	2.8e-07	2.69e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—APOE—hypertension	2.79e-07	2.68e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—VEGFA—hypertension	2.79e-07	2.68e-06	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL6—hypertension	2.79e-07	2.68e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	2.78e-07	2.67e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—AGT—hypertension	2.78e-07	2.67e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GNAS—hypertension	2.77e-07	2.67e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CXCL8—hypertension	2.77e-07	2.66e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—NOS3—hypertension	2.76e-07	2.66e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PIK3R1—hypertension	2.76e-07	2.66e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CAV1—hypertension	2.76e-07	2.66e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—APOA1—hypertension	2.76e-07	2.65e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—MTHFR—hypertension	2.76e-07	2.65e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—EP300—hypertension	2.75e-07	2.65e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CALM1—hypertension	2.73e-07	2.63e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—MTHFR—hypertension	2.73e-07	2.63e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—APOE—hypertension	2.72e-07	2.62e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PPARG—hypertension	2.72e-07	2.62e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOB—hypertension	2.72e-07	2.61e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PPARA—hypertension	2.7e-07	2.6e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PIK3R1—hypertension	2.7e-07	2.6e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—NOS3—hypertension	2.7e-07	2.6e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CAV1—hypertension	2.7e-07	2.59e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—APOA1—hypertension	2.69e-07	2.59e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—MYC—hypertension	2.69e-07	2.59e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—POMC—hypertension	2.68e-07	2.58e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TGFB1—hypertension	2.68e-07	2.58e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PPARA—hypertension	2.68e-07	2.58e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—SRC—hypertension	2.67e-07	2.57e-06	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—AKT1—hypertension	2.67e-07	2.57e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—INS—hypertension	2.67e-07	2.57e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—AKT1—hypertension	2.66e-07	2.56e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GSTM1—hypertension	2.64e-07	2.54e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—IL6—hypertension	2.63e-07	2.53e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—EGFR—hypertension	2.63e-07	2.53e-06	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—IL6—hypertension	2.63e-07	2.53e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—TH—hypertension	2.62e-07	2.52e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—AGT—hypertension	2.62e-07	2.52e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CALM2—hypertension	2.61e-07	2.51e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—VEGFA—hypertension	2.61e-07	2.51e-06	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—IL6—hypertension	2.6e-07	2.5e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—AGT—hypertension	2.6e-07	2.5e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—LPL—hypertension	2.59e-07	2.49e-06	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TP53—hypertension	2.59e-07	2.49e-06	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TP53—hypertension	2.59e-07	2.49e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CALM1—hypertension	2.57e-07	2.48e-06	CbGpPWpGaD
Sorafenib—RAF1—Disease—IL6—hypertension	2.57e-07	2.47e-06	CbGpPWpGaD
Sorafenib—RAF1—Immune System—AKT1—hypertension	2.57e-07	2.47e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—APOE—hypertension	2.57e-07	2.47e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—MYC—hypertension	2.56e-07	2.47e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TGFB1—hypertension	2.56e-07	2.46e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CALM1—hypertension	2.55e-07	2.45e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GCG—hypertension	2.55e-07	2.45e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—SLC2A4—hypertension	2.55e-07	2.45e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—APOE—hypertension	2.54e-07	2.45e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CAV1—hypertension	2.54e-07	2.44e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ADCY5—hypertension	2.54e-07	2.44e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—APOA1—hypertension	2.54e-07	2.44e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GPX1—hypertension	2.53e-07	2.43e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PTGS2—hypertension	2.53e-07	2.43e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CAV1—hypertension	2.52e-07	2.42e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—APOA1—hypertension	2.51e-07	2.42e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—EGFR—hypertension	2.51e-07	2.41e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MMP9—hypertension	2.5e-07	2.41e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PRKCA—hypertension	2.5e-07	2.41e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CYP1A1—hypertension	2.5e-07	2.41e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CDKN1A—hypertension	2.5e-07	2.4e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PTEN—hypertension	2.49e-07	2.39e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PTGS2—hypertension	2.47e-07	2.38e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GOT1—hypertension	2.47e-07	2.37e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CD36—hypertension	2.46e-07	2.37e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TP53—hypertension	2.46e-07	2.36e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TP53—hypertension	2.45e-07	2.36e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ALB—hypertension	2.45e-07	2.35e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MAPK8—hypertension	2.44e-07	2.34e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PPARG—hypertension	2.43e-07	2.34e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—AKT1—hypertension	2.43e-07	2.34e-06	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—AKT1—hypertension	2.43e-07	2.33e-06	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—AKT1—hypertension	2.4e-07	2.31e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—STK11—hypertension	2.4e-07	2.31e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CYP19A1—hypertension	2.4e-07	2.31e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MYC—hypertension	2.4e-07	2.31e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—POMC—hypertension	2.4e-07	2.3e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TGFB1—hypertension	2.39e-07	2.3e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—INS—hypertension	2.38e-07	2.29e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—EP300—hypertension	2.37e-07	2.28e-06	CbGpPWpGaD
Sorafenib—RAF1—Disease—AKT1—hypertension	2.37e-07	2.28e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PPARG—hypertension	2.37e-07	2.28e-06	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—IL6—hypertension	2.37e-07	2.28e-06	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—IL6—hypertension	2.37e-07	2.28e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—EGFR—hypertension	2.34e-07	2.25e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—NOS3—hypertension	2.34e-07	2.25e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PIK3R1—hypertension	2.34e-07	2.25e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—POMC—hypertension	2.34e-07	2.25e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—MTHFR—hypertension	2.33e-07	2.24e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—INS—hypertension	2.33e-07	2.24e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—SRC—hypertension	2.31e-07	2.22e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PPARA—hypertension	2.29e-07	2.2e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—IL6—hypertension	2.25e-07	2.16e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—VEGFA—hypertension	2.25e-07	2.16e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—IL6—hypertension	2.24e-07	2.16e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PPARG—hypertension	2.23e-07	2.15e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—COMT—hypertension	2.23e-07	2.14e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—AGT—hypertension	2.22e-07	2.13e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PPARG—hypertension	2.21e-07	2.13e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TP53—hypertension	2.21e-07	2.12e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PTEN—hypertension	2.21e-07	2.12e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—POMC—hypertension	2.2e-07	2.12e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GNB3—hypertension	2.2e-07	2.11e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PPARGC1A—hypertension	2.2e-07	2.11e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—INS—hypertension	2.19e-07	2.11e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—HMOX1—hypertension	2.19e-07	2.1e-06	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—AKT1—hypertension	2.19e-07	2.1e-06	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—AKT1—hypertension	2.19e-07	2.1e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—POMC—hypertension	2.18e-07	2.1e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ALB—hypertension	2.18e-07	2.1e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CALM1—hypertension	2.18e-07	2.1e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOE—hypertension	2.17e-07	2.09e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—INS—hypertension	2.17e-07	2.09e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CAT—hypertension	2.16e-07	2.08e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PTEN—hypertension	2.16e-07	2.07e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CAV1—hypertension	2.15e-07	2.07e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOA1—hypertension	2.15e-07	2.07e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PTGS2—hypertension	2.14e-07	2.06e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GNAS—hypertension	2.14e-07	2.06e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ALB—hypertension	2.13e-07	2.05e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TP53—hypertension	2.11e-07	2.03e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—EP300—hypertension	2.1e-07	2.02e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOB—hypertension	2.1e-07	2.02e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PIK3R1—hypertension	2.09e-07	2.01e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—NOS3—hypertension	2.09e-07	2.01e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—AKT1—hypertension	2.08e-07	2e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—AKT1—hypertension	2.07e-07	1.99e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MYC—hypertension	2.07e-07	1.99e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TGFB1—hypertension	2.06e-07	1.99e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—EP300—hypertension	2.06e-07	1.98e-06	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—AKT1—hypertension	2.04e-07	1.97e-06	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—AKT1—hypertension	2.04e-07	1.97e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PIK3R1—hypertension	2.04e-07	1.96e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—NOS3—hypertension	2.04e-07	1.96e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GSTM1—hypertension	2.04e-07	1.96e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—EGFR—hypertension	2.02e-07	1.95e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—IL6—hypertension	2.02e-07	1.94e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ALB—hypertension	2.01e-07	1.93e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—LPL—hypertension	2e-07	1.92e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ALB—hypertension	1.99e-07	1.92e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TP53—hypertension	1.97e-07	1.89e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ADCY5—hypertension	1.96e-07	1.88e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GPX1—hypertension	1.95e-07	1.88e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PRKCA—hypertension	1.93e-07	1.86e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CYP1A1—hypertension	1.93e-07	1.86e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—IL6—hypertension	1.93e-07	1.85e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—NOS3—hypertension	1.92e-07	1.85e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PIK3R1—hypertension	1.92e-07	1.85e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PTGS2—hypertension	1.91e-07	1.84e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—NOS3—hypertension	1.91e-07	1.83e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PIK3R1—hypertension	1.91e-07	1.83e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CD36—hypertension	1.9e-07	1.83e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PPARG—hypertension	1.89e-07	1.82e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PTEN—hypertension	1.87e-07	1.8e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—POMC—hypertension	1.87e-07	1.8e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PTGS2—hypertension	1.87e-07	1.79e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—AKT1—hypertension	1.86e-07	1.79e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—INS—hypertension	1.86e-07	1.79e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—IL6—hypertension	1.8e-07	1.73e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—MTHFR—hypertension	1.8e-07	1.73e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—EP300—hypertension	1.78e-07	1.71e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—AKT1—hypertension	1.78e-07	1.71e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PPARA—hypertension	1.77e-07	1.7e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PTGS2—hypertension	1.76e-07	1.69e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PTGS2—hypertension	1.74e-07	1.68e-06	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—AKT1—hypertension	1.73e-07	1.67e-06	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—AKT1—hypertension	1.72e-07	1.65e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—AGT—hypertension	1.71e-07	1.65e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ALB—hypertension	1.7e-07	1.64e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TP53—hypertension	1.7e-07	1.63e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CALM1—hypertension	1.68e-07	1.62e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOE—hypertension	1.68e-07	1.61e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PTEN—hypertension	1.67e-07	1.6e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—AKT1—hypertension	1.66e-07	1.6e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CAV1—hypertension	1.66e-07	1.6e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOA1—hypertension	1.66e-07	1.59e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PIK3R1—hypertension	1.63e-07	1.57e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—NOS3—hypertension	1.63e-07	1.57e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PTEN—hypertension	1.63e-07	1.56e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—EP300—hypertension	1.59e-07	1.53e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—IL6—hypertension	1.56e-07	1.5e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—EP300—hypertension	1.55e-07	1.49e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PTEN—hypertension	1.53e-07	1.47e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PTEN—hypertension	1.52e-07	1.46e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PTGS2—hypertension	1.49e-07	1.43e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—EP300—hypertension	1.46e-07	1.41e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PPARG—hypertension	1.46e-07	1.4e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—EP300—hypertension	1.45e-07	1.39e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—POMC—hypertension	1.44e-07	1.39e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—AKT1—hypertension	1.43e-07	1.38e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—INS—hypertension	1.43e-07	1.38e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ALB—hypertension	1.31e-07	1.26e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PTEN—hypertension	1.3e-07	1.25e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—AKT1—hypertension	1.27e-07	1.22e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PIK3R1—hypertension	1.26e-07	1.21e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—NOS3—hypertension	1.26e-07	1.21e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—AKT1—hypertension	1.24e-07	1.19e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—EP300—hypertension	1.24e-07	1.19e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PTGS2—hypertension	1.15e-07	1.11e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—AKT1—hypertension	1.08e-07	1.03e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PTEN—hypertension	1e-07	9.64e-07	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—AKT1—hypertension	9.6e-08	9.24e-07	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—EP300—hypertension	9.56e-08	9.19e-07	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—AKT1—hypertension	9.37e-08	9.02e-07	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—AKT1—hypertension	8.83e-08	8.5e-07	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—AKT1—hypertension	8.76e-08	8.42e-07	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—AKT1—hypertension	7.48e-08	7.2e-07	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—AKT1—hypertension	5.78e-08	5.55e-07	CbGpPWpGaD
